Page last updated: 2024-10-21

2-hydroxysaclofen and Seizures

2-hydroxysaclofen has been researched along with Seizures in 1 studies

2-hydroxysaclofen: structure given in first source

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research Excerpts

ExcerptRelevanceReference
"Isoguvacine pre-treatment prevented the increase in DOPAC concentrations in the median eminence produced by SR 95531."1.29GABAergic regulation of tuberoinfundibular dopaminergic neurons in the male rat. ( Goudreau, JL; Lookingland, KJ; Moore, KE; Wagner, EJ, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wagner, EJ1
Goudreau, JL1
Moore, KE1
Lookingland, KJ1

Other Studies

1 other study available for 2-hydroxysaclofen and Seizures

ArticleYear
GABAergic regulation of tuberoinfundibular dopaminergic neurons in the male rat.
    Brain research, 1994, Oct-03, Volume: 659, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Baclofen; Dopamine; GABA Agonists; GABA Antagonists; gamma-

1994
chemdatabank.com